German oncology clinics are working with Optima Pharma to create an automated manufacturing unit for decentralised production of CAR T-cell therapies in treatment centres.
AffyImmune , effective ways to use CAR T cells against solid cancers, announced today that FDA granted Fast Track designation to its lead compound, for the treatment of anaplastic thyroid cancer and refractory poorly differentiated thyroid cancer.
Mustang Bio, Inc. ("Mustang") (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers ...